Advent Access is a medical technology startup focused on end-stage renal disease management. A Stanford StartX company and spin-off from A*STAR, Advent’s mission is to pioneer innovations to significantly reduce dialysis cost and restore quality of life for kidney failure patients. The company’s first product is the av-Guardian™ - an award-winning implant technology that aims to improve vascular access reliability, enable less-painful self-cannulation and, in the long run, potentially reduce vascular access related hospitalizations. The av-Guardian™ forms a key component of Advent Access’ dialysis-machine agnostic platform to empower patients to perform hemodialysis independently, safely and more affordably - at home or in novel care environments. The startup is founded with an executive management and investors with a collective experience of pioneering more than ten startups in medtech and a track record of successful IPOs and exits. The company has raised >$5.6M of private investments and research grants to date. For more information, please refer to www.adventaccess.com
| Website | http://adventaccess.com |
| Revenue | $6 million |
| Funding | $1.9 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2015 |
| Technologies |
G Suite
,
Gmail
,
Wix
+1 more
(view full list)
|
| Industry | Medical Devices, Health Care, Medical, Medical Device |
| Keywords | Renal Disease, Dialysis, Medical Technology, Healthcare Technology, End Stage Renal Disease, Health Tech Startup, Renal Care, Kidney Disease, Medical Innovation, Healthcare Innovation, Cost Reduction, Quality Of Life, Patient Care, Medical Solutions, Healthcare Solutions, Biotechnology |
| Competitors | Zayo Group, Calix, Netcracker Technology, Adtran, Sierra Wireless, OATI, FiberLight, LLC, Coriant, Inc., 深圳新飞通光电子技术有限公司, ClearAccess +42 more (view full list) |
Looking for a particular Advent Access employee's phone or email?
The Advent Access annual revenue was $6 million in 2026.